FA
AVNS

FMA Advisory’s Avanos Medical AVNS Stock Holding History

FMA Advisory’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$4K Buy
+100
New +$4.49K ﹤0.01% 319

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
RP
RR Partners New York $929M AUM 110.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FMA Advisory's AVNS Position: Q2 2015 in Review

FMA Advisory opened a new position in Avanos Medical (AVNS) in Q2 2015: 100 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #319 among its holdings.

419 funds tracked by Wall St. Rank hold AVNS as of Q2 2015.

  • FMA Advisory held 100 shares of Avanos Medical worth $4K as of Q2 2015.
  • Avanos Medical was a new FMA Advisory position in Q2 2015.
  • Avanos Medical made up ﹤0.01% of FMA Advisory's portfolio in Q2 2015, its #319 holding.
  • 419 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.